HCPCS Level II
J1459
Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg
Codes near J1459
These sit next to J1459 in the CMS Level II file. All J codes
- J1454Injection, fosnetupitant 235 mg and palonosetron 0.25 mg
- J1455Injection, foscarnet sodium, per 1000 mg
- J1456Injection, fosaprepitant (teva), not therapeutically equivalent to j1453, 1 mg
- J1457Injection, gallium nitrate, 1 mg
- J1458Injection, galsulfase, 1 mg
- J1460Injection, gamma globulin, intramuscular, 1 cc
- J1551Injection, immune globulin (cutaquig), 100 mg
- J1552Injection, immune globulin (alyglo), 500 mg
- J1553Injection, immune globulin (yimmugo), 100 mg
- J1554Injection, immune globulin (asceniv), 500 mg
NDC crosswalk
| NDC | Drug | Labeler | Billable units |
|---|---|---|---|
| 44206-0436-05 | Privigen | CSL Behring L.L.C. | 10 |
| 44206-0437-10 | Privigen | CSL Behring L.L.C. | 20 |
| 44206-0438-20 | Privigen | CSL Behring L.L.C. | 40 |
| 44206-0439-40 | Privigen | CSL Behring L.L.C. | 80 |
Source: CMS ASP NDC-HCPCS crosswalk, effective October 1, 2026 through December 31, 2026.